Share
𝕏 Facebook LinkedIn

1950 MHz Electromagnetic Fields Ameliorate Aβ Pathology in Alzheimer's Disease Mice.

PAPER pubmed Current Alzheimer research 2015 Animal study Effect: benefit Evidence: Low

Abstract

The involvement of radiofrequency electromagnetic fields (RF-EMF) in the neurodegenerative disease, especially Alzheimer's disease (AD), has received wide consideration, however, outcomes from several researches have not shown consistency. In this study, we determined whether RF-EMF influenced AD pathology in vivo using Tg-5xFAD mice as a model of AD-like amyloid β (Aβ) pathology. The transgenic (Tg)-5xFAD and wild type (WT) mice were chronically exposed to RF-EMF for 8 months (1950 MHz, SAR 5W/kg, 2 hrs/day, 5 days/week). Notably, chronic RFEMF exposure significantly reduced not only Aβ plaques, APP, and APP carboxyl-terminal fragments (CTFs) in whole brain including hippocampus and entorhinal cortex but also the ratio of Aβ42 and Aβ40 peptide in the hippocampus of Tg-5xFAD mice. We also found that parenchymal expression of β-amyloid precursor protein cleaving enzyme 1(BACE1) and neuroinflammation were inhibited by RF-EMF exposure in Tg-5xFAD. In addition, RF-EMF was shown to rescue memory impairment in Tg-5xFAD. Moreover, gene profiling from microarray data using hippocampus of WT and Tg- 5xFAD following RF-EMF exposure revealed that 5 genes (Tshz2, Gm12695, St3gal1, Isx and Tll1), which are involved in Aβ, are significantly altered inTg-5xFAD mice, exhibiting different responses to RF-EMF in WT or Tg-5xFAD mice; RF-EMF exposure in WT mice showed similar patterns to control Tg-5xFAD mice, however, RF-EMF exposure in Tg- 5xFAD mice showed opposite expression patterns. These findings indicate that chronic RF-EMF exposure directly affects Aβ pathology in AD but not in normal brain. Therefore, RF-EMF has preventive effects against AD-like pathology in advanced AD mice with a high expression of Aβ, which suggests that RF-EMF can have a beneficial influence on AD.

AI evidence extraction

At a glance
Study type
Animal study
Effect direction
benefit
Population
Tg-5xFAD transgenic mice (Alzheimer’s disease model) and wild type mice
Sample size
—
Exposure
RF · 1950 MHz · 5 W/kg · 8 months; 2 hrs/day, 5 days/week
Evidence strength
Low
Confidence: 78% · Peer-reviewed: yes

Main findings

Tg-5xFAD and wild type mice were chronically exposed to 1950 MHz RF-EMF (SAR 5 W/kg) for 8 months. In Tg-5xFAD mice, exposure significantly reduced Aβ plaques, APP and APP-CTFs in whole brain (including hippocampus and entorhinal cortex), reduced the hippocampal Aβ42/Aβ40 ratio, inhibited BACE1 expression and neuroinflammation, and rescued memory impairment. Gene profiling indicated five Aβ-related genes were significantly altered in Tg-5xFAD mice with different response patterns in WT versus Tg-5xFAD following exposure.

Outcomes measured

  • Aβ plaques
  • APP and APP carboxyl-terminal fragments (CTFs)
  • Hippocampal Aβ42/Aβ40 ratio
  • BACE1 expression
  • Neuroinflammation
  • Memory impairment/behavior
  • Hippocampal gene expression (microarray; Tshz2, Gm12695, St3gal1, Isx, Tll1)

Limitations

  • Sample size not reported in abstract
  • Exposure source/setup (e.g., device/field characteristics beyond frequency and SAR) not described in abstract
  • Findings are from an animal model; relevance to humans not addressed in abstract
View raw extracted JSON
{
    "study_type": "animal",
    "exposure": {
        "band": "RF",
        "source": null,
        "frequency_mhz": 1950,
        "sar_wkg": 5,
        "duration": "8 months; 2 hrs/day, 5 days/week"
    },
    "population": "Tg-5xFAD transgenic mice (Alzheimer’s disease model) and wild type mice",
    "sample_size": null,
    "outcomes": [
        "Aβ plaques",
        "APP and APP carboxyl-terminal fragments (CTFs)",
        "Hippocampal Aβ42/Aβ40 ratio",
        "BACE1 expression",
        "Neuroinflammation",
        "Memory impairment/behavior",
        "Hippocampal gene expression (microarray; Tshz2, Gm12695, St3gal1, Isx, Tll1)"
    ],
    "main_findings": "Tg-5xFAD and wild type mice were chronically exposed to 1950 MHz RF-EMF (SAR 5 W/kg) for 8 months. In Tg-5xFAD mice, exposure significantly reduced Aβ plaques, APP and APP-CTFs in whole brain (including hippocampus and entorhinal cortex), reduced the hippocampal Aβ42/Aβ40 ratio, inhibited BACE1 expression and neuroinflammation, and rescued memory impairment. Gene profiling indicated five Aβ-related genes were significantly altered in Tg-5xFAD mice with different response patterns in WT versus Tg-5xFAD following exposure.",
    "effect_direction": "benefit",
    "limitations": [
        "Sample size not reported in abstract",
        "Exposure source/setup (e.g., device/field characteristics beyond frequency and SAR) not described in abstract",
        "Findings are from an animal model; relevance to humans not addressed in abstract"
    ],
    "evidence_strength": "low",
    "confidence": 0.7800000000000000266453525910037569701671600341796875,
    "peer_reviewed_likely": "yes",
    "keywords": [
        "radiofrequency electromagnetic fields",
        "RF-EMF",
        "1950 MHz",
        "SAR 5 W/kg",
        "Alzheimer's disease",
        "Tg-5xFAD",
        "amyloid beta",
        "Aβ plaques",
        "APP",
        "BACE1",
        "neuroinflammation",
        "memory",
        "microarray"
    ],
    "suggested_hubs": []
}

AI can be wrong. Always verify against the paper.

AI-extracted fields are generated from the abstract/metadata and may be incomplete or incorrect. This content is for informational purposes only and is not medical advice.

Comments

Log in to comment.

No comments yet.